Abstract:Background: Prostate cancer (PCa) is one of the most prevalent malignancies in males worldwide. Increasing research attention has focused on the PCa microenvironment, which plays a crucial role in tumor progression and therapy resistance. This review aims to provide a comprehensive overview of the key components of the PCa microenvironment, including immune cells, vascular systems, stromal cells, and microbiota, and explore their implications for diagnosis and treatment. Methods: Keywords such as "prostate cancer", "tumor microenvironment", "immune cells", "vascular system", "stromal cells", and "microbiota" were used for literature retrieval through online databases including PubMed and Web of Science. Studies related to the PCa microenvironment were selected, with a particular focus on those discussing the roles of immune cells, vascular systems, stromal cells, and microbiota in the development, progression, and treatment of PCa. The selection criteria prioritized peer-reviewed articles published in the last five years, aiming to summarize and analyze the latest research advancements and clinical relevance regarding the PCa microenvironment. Results: The PCa microenvironment is highly complex and dynamic, with immune cells contributing to immunosuppressive conditions, stromal cells promoting tumor growth, and microbiota potentially affecting androgen metabolism. Vascular systems support angiogenesis, which fosters tumor expansion. Understanding these components offers insight into the mechanisms driving PCa progression and opens avenues for novel therapeutic strategies targeting the tumor microenvironment. Conclusions: A deeper understanding of the PCa microenvironment is crucial for advancing diagnostic techniques and developing precision therapies. This review highlights the potential of targeting the microenvironment to improve patient outcomes, emphasizing its significance in the broader context of PCa research and treatment innovation.

Tumor microenvironment heterogeneity an important mediator of prostate cancer progression and therapeutic resistance

Systematic dissection of phenotypic, functional, and tumorigenic heterogeneity of human prostate cancer cells

Tumor heterogeneity reshapes the tumor microenvironment to influence drug resistance

A narrative review of tumor heterogeneity and challenges to tumor drug therapy

Heterogeneity of the tumor immune microenvironment and its clinical relevance

Heterogeneity in Primary Tumors and Corresponding Metastases: Could It Provide Us with Any Hints to Personalize Cancer Therapy?

Tumor Microenvironment Heterogeneity, Potential Therapeutic Avenues, and Emerging Therapies

The role of tumor microenvironment in drug resistance: emerging technologies to unravel breast cancer heterogeneity

From complexity to clarity: unravelling tumor heterogeneity through the lens of tumor microenvironment for innovative cancer therapy

Interplay between Solid Tumors and Tumor Microenvironment

Heterogeneity in Primary Colorectal Cancer and Its Corresponding Metastases: a Potential Reason of EGFR-targeted Therapy Failure?

Bladder Tumor Heterogeneity: The Impact on Clinical Treatment

Heterogeneity of the tumor immune microenvironment and clinical interventions

Intratumoral heterogeneity and genetic characteristics of prostate cancer

Wnt/β-catenin Signaling Contributes to Prostate Cancer Heterogeneity Through Reciprocal Suppression of H3K27 Trimethylation.

Roles of tumor heterogeneity in the development of drug resistance: A call for precision therapy

Prostate cancer microenvironment: multidimensional regulation of immune cells, vascular system, stromal cells, and microbiota

Metabolic Regulation of Prostate Cancer Heterogeneity and Plasticity.

Metabolic Heterogeneity in Cancer: an Overview and Therapeutic Implications

Roles of immune microenvironment heterogeneity in therapy-associated biomarkers in lung cancer.